Stock listing

gettex:8E8 Elicera Therapeutics AB Aktie

German listing (gettex) of Elicera Therapeutics AB · home listing Stockholm:ELIC

Follow Elicera Therapeutics AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:ELIC

2.62 SEK -0.05 (-2.1%)

Close on Nov 3, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:ELIC

Past year -58.2% · daily closes, Nov 3, 2025 – Nov 3, 2026, adjusted for splits
Day range
2.52 – 2.71 SEKNov 3, 2026
Volume
295,914 sharesNov 3, 2026
Market cap
174.5M SEKAt the close on Nov 3, 2026 · price × 66.74M shares outstanding
52-week range
2.25 – 7.00 SEKLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
Traded on an average day
923,819 SEKMedian day 208,745 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Elicera Therapeutics AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:ELIC · Home2.615 SEK-0.055 (-2.1%)295,9142.712.712.522.67Close on Nov 3, 2026
Frankfurt:8E8€0.212 EUR-0.006 (-2.5%)—€0.219€0.219€0.212€0.218Close on Oct 30, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 3, 2026 · OMXSTO:ELIC · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
2.615-0.055-2.1%2.712.712.52295,914
2.67+0.015+0.6%2.692.7352.63125,228
2.655-0.085-3.1%2.752.7952.64579,479
2.74-0.105-3.7%2.7752.8352.7096,436
2.845-0.01-0.4%2.852.852.7687,112
2.855+0.10+3.6%2.802.8752.74593,817
2.755-0.045-1.6%2.7952.8252.72107,164
2.800.000.0%2.912.912.7781,630
2.80-0.085-2.9%2.8852.9052.8098,442
2.885+0.025+0.9%2.862.9352.83107,336
2.86+0.01+0.4%2.902.902.8288,055
2.85-0.045-1.6%2.903.202.825109,565
2.895-0.095-3.2%2.8952.992.85168,726
2.99-0.10-3.2%3.093.1152.845361,678
3.09+0.15+5.1%2.9553.142.88334,453
2.94+0.04+1.4%3.0053.0052.83250,183
2.90+0.145+5.3%2.7053.232.681,269,814
2.755-0.015-0.5%2.762.792.675155,477
2.77-0.065-2.3%2.782.782.71135,501
2.835+0.005+0.2%2.8352.9052.795185,303
2.83+0.055+2.0%2.772.862.69587,382
2.775-0.08-2.8%2.8552.8652.71153,198
2.855+0.07+2.5%2.7852.8652.75193,402
2.785+0.015+0.5%2.802.802.73100,160
2.770.000.0%2.772.822.735127,922
2.77+0.105+3.9%2.6552.782.605277,506
2.665-0.05-1.8%2.722.742.66366,095
2.715-0.02-0.7%2.742.7452.655193,287
2.735+0.025+0.9%2.6552.7652.6171,568
2.71-0.02-0.7%2.792.792.605211,616
2.73+0.015+0.6%2.722.8952.685230,611
2.715-0.07-2.5%2.792.862.61330,182
2.785-0.02-0.7%2.8352.8352.715112,310
2.805-0.115-3.9%2.9752.9752.75419,625
2.92-0.055-1.8%2.972.972.835119,239
2.975-0.01-0.3%3.023.0752.935284,852
2.985+0.105+3.6%2.8753.022.775389,480
2.88+0.155+5.7%2.7552.882.685343,869
2.725-0.115-4.0%2.832.832.71141,265
2.84+0.14+5.2%2.8052.852.74476,411
2.70-0.13-4.6%2.7652.7852.645132,440
2.83-0.05-1.7%2.912.922.76208,745
2.88+0.02+0.7%2.862.892.81305,094
2.86+0.05+1.8%2.8252.872.765240,759
2.81+0.15+5.6%2.7052.852.66230,763
2.66-0.07-2.6%2.792.812.625241,768
2.73-0.12-4.2%2.8552.862.70408,868
2.85+0.275+10.7%2.6752.952.651,444,464
2.575-0.07-2.6%2.6852.702.575182,247
2.645-0.05-1.9%2.662.702.595269,138
2.695+0.07+2.7%2.662.702.595169,939
2.625+0.035+1.4%2.562.662.54298,136
2.59-0.01-0.4%2.542.602.505302,790
2.60-0.045-1.7%2.682.742.53260,838
2.645-0.04-1.5%2.6752.7652.58306,739
2.685-0.06-2.2%2.752.7652.615498,839
2.745-0.125-4.4%2.882.882.68540,607
2.87-0.075-2.5%2.952.952.82460,092
2.945-0.02-0.7%3.0453.052.84397,160
2.965+0.015+0.5%3.203.272.8751,339,469
2.95+0.455+18.2%2.433.332.413,611,140
2.495-0.035-1.4%2.532.542.425186,672
2.53+0.145+6.1%2.332.532.32528,995
2.385+0.055+2.4%2.3852.3852.32144,265
2.33-0.02-0.9%2.352.3952.32103,573
2.35+0.02+0.9%2.3452.392.30134,313
2.33-0.06-2.5%2.3952.412.29170,026
Ticker
gettex:8E8
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
gettex
Currency
EUR

What changed lately

Latest news

Elicera announces outcome of the rights issue

Jun 1, 2026

Closed 2.81 (-2.8%) on Jun 2, 2026

Elicera Therapeutics announces that the final reporting and final payment from the EIC Accelerator for the CARMA study have been approved

May 25, 2026

Closed 3.00 (-0.2%) on May 25, 2026

Elicera publishes information document regarding the rights issue

May 11, 2026

Closed 3.15 (-0.5%) on May 11, 2026

Elicera Therapeutics carries out a rights issue of approximately SEK 73 million

Apr 21, 2026

Closed 3.42 (-32.4%) on Apr 21, 2026

Elicera Therapeutics receives Notice of Allowance for Japanease patent protecting the ELC-401 CAR T-cell candidate

Mar 11, 2026

Closed 5.68 (-1.7%) on Mar 11, 2026

Elicera Therapeutics reports complete metabolic response (CMR) and well tolerated treatment in first two patients of cohort 3 in CARMA study, bringing total CMR to 6 out of 8 treated patients

Mar 6, 2026

Closed 6.50 (-4.4%) on Mar 6, 2026

Elicera Therapeutics provides update on preclinical CAR T-cell program ELC-401 for glioblastoma: preclinical development concluded and clinical trial planning underway

Feb 27, 2026

Closed 6.17 (-1.3%) on Feb 27, 2026

Elicera Therapeutics announces abstract acceptance at ISCT 2026 Dublin: Complete metabolic response achieved in four of six patients with iTANK-armed ELC-301 in CARMA Lymphoma Study

Feb 11, 2026

Closed 5.10 (+2.1%) on Feb 11, 2026

Elicera Therapeutics presents positive phase I/IIa data for ELC-100

Jan 9, 2026

Closed 5.92 (+13.8%) on Jan 9, 2026

Elicera Therapeutics announces final data from its Phase I/IIa trial demonstrating a favorable safety profile and promising efficacy signals of oncolytic virus ELC-100 in neuroendocrine tumors

Jan 9, 2026

Closed 5.92 (+13.8%) on Jan 9, 2026

All Elicera Therapeutics AB news

Elicera Therapeutics AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
12 in the last 12 months · 12 in all · newest Jun 1, 2026 · oldest 2025

Where Elicera Therapeutics AB is listed

ListingExchangeCountryCurrency
Stockholm:ELIC · Home listingStockholmSwedenSEK
Frankfurt:8E8FrankfurtGermanyEUR
gettex:8E8 · This pagegettexGermanyEUR
Munich:8E8MunichGermanyEUR
Stockholm:ELICBTAStockholmSwedenSEK

Log in to ask 6ix AI your own questions about Elicera Therapeutics AB.